VK

Vasantbhai Kantilal Patel

Director Director DIN 01020367
DIN 01020367 First appointment May 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 1999
Shareholding value •••• Premium profile

About Vasantbhai Kantilal Patel

Data last updated:

Vasantbhai Kantilal Patel was a Director at Bvk's Bioscience Private Limited (2015–2021) and Whole-Time Director at Scion Pharma Private Limited (1999–2021). The companies operate in Pharma.

DIN 01020367
Primary Designation Director
Industry Pharma
First Appointment 25 May 1999

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bvk's Bioscience Private Limited U24100GJ2015PTC083300
Director25 May 20152015₹5.38 Cr (FY 2025)Active
Scion Pharma Private Limited U24231GJ1999PTC036036
Whole-Time Director25 May 19991999₹2.21 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bvk's Bioscience Private Limited
Scion Pharma Private Limited
Premium access

Shareholding and investment profile for Vasantbhai Kantilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasantbhai Kantilal Patel

Vasantbhai Kantilal Patel was first appointed on 25 May 1999 as Whole-Time Director at Scion Pharma Private Limited. The most recent appointment on record is 25 May 2015 at Bvk's Bioscience Private Limited.

Vasantbhai Kantilal Patel held 2 earlier board appointments: Bvk's Bioscience Private Limited (Director, 25 May 2015 to 26 Oct 2021); Scion Pharma Private Limited (Whole-Time Director, 25 May 1999 to 26 Oct 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available